Genetic instability of micrometastatic tumour cells and/or changes in the immune system, such as differences in the ratio between cytotoxic CD8 T-lymphocytes and regulatory CD4 T-regulatory cells, being implicated [16, 17]. The gene discussed is CD8A; the disease is neoplasm.